AFOCX
Price
$25.86
Change
-$0.12 (-0.46%)
Updated
Jul 13 closing price
Net Assets
3.92M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

AFOCX vs VSTSX

AFOCX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
AFOCX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFOCX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. AFOCX (3.92M). VSTSX pays higher dividends than AFOCX: VSTSX (1.07) vs AFOCX (0.81). AFOCX was incepted earlier than VSTSX: AFOCX (7 years) vs VSTSX (10 years). AFOCX (1.60) is less costly to investors than VSTSX (0.01). AFOCX is a more actively managed with annual turnover of: 111.01 vs. VSTSX (3.00). AFOCX has a lower initial minimum investment than VSTSX: AFOCX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. AFOCX (12.64). VSTSX return over 5 years is better than : 66.56 vs. AFOCX (12.02).
AFOCXVSTSXAFOCX / VSTSX
Total Expense Ratio0.980.019,800%
Annual Report Gross Expense Ratio1.600.0116,000%
Fund Existence7 years10 years-
Gain YTD12.12811.205108%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.92M2.3T0%
Annual Yield % from dividends0.811.0775%
Returns for 1 year12.6421.4859%
Returns for 3 years22.2467.0633%
Returns for 5 years12.0266.5618%
Returns for 10 yearsN/A239.53-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I